Data / Drug companies / Potassium citrate
Potassium citrate: 17 companies and 49 products in the FDA NDC directory
Potassium citrate is listed in the FDA National Drug Code Directory by 17 companies, with 49 products in commercial distribution. 43 of the products (87.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, and the newest product started marketing on September 12, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 49
- Generic (ANDA) products
- 43 (87.8%)
- Application numbers
- 7
- Routes
- Oral
- Brand names
- Urocit-K
- openFDA record search
- api.fda.gov
Companies that list potassium citrate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 8 | tablet, extended release; tablet | Generic drugs (ANDA) | February 15, 2021 |
| Bryant Ranch Prepack | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | February 15, 2021 |
| Actavis Pharma, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | May 30, 2018 |
| Bryant Ranch Prepack | 3 | tablet, extended release | Generic drugs (ANDA) | March 16, 2020 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | February 15, 2021 |
| Golden State Medical Supply, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | August 6, 2014 |
| Strides Pharma Inc. | 3 | tablet | Generic drugs (ANDA) | November 1, 2017 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | February 25, 2021 |
| Zydus Lifesciences Limited | 3 | tablet, extended release | Generic drugs (ANDA) | August 12, 2014 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | August 12, 2014 |
| Ani Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | March 16, 2020 |
| BioComp Pharma, Inc. | 2 | tablet | Authorized generics (NDA) | December 3, 2024 |
| Mission Pharmacal Company | 2 | tablet, extended release | New drug applications (NDA) | January 27, 2010 |
| Remedyrepack Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | September 12, 2025 |
| Rising Pharma Holdings, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | December 15, 2024 |
| Upsher-Smith Laboratories, LLC | 2 | tablet | New drug applications (NDA) | September 1, 2006 |
| American Health Packaging | 1 | tablet, extended release | Generic drugs (ANDA) | November 12, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 37 | 75.5% |
| Tablet | 12 | 24.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 43 | 87.8% |
| New drug applications (NDA) | 4 | 8.2% |
| Authorized generics (NDA) | 2 | 4.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Anti-coagulant | 49 |
| Calculi Dissolution Agent | 49 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.